Navigation Links
A New Diagnostic Approach To Pediatric Interstitial Lung Disease

Chronic interstitial lung disease (ILD) comprises a large, heterogeneous group of rare pulmonary disorders //characterized by diffuse infiltrates, restrictive lung disease, and abnormal gas exchange with considerable mortality and morbidity. ILD presents enormous diagnostic challenges because the differential diagnosis includes more than 100 conditions in both adults2 and children.

Researchers from Texas and Colorado conducted a descriptive, observational study was to evaluate the value of a systematic approach to the diagnosis of pediatric ILD. The study appears in the journal Pediatrics (vol. 101). In this prospective study, the researchers evaluated 51 children presenting with ILD of unknown etiology during a 3-year period. Specific clinical information regarding history, physical examination, diagnostic evaluation, and final diagnosis was recorded on each patient.

A specific diagnosis was established by history and physical examination alone in 1 patient, noninvasive tests alone in 8 others, and invasive tests, including lung biopsy, in another 26. Of the remaining patients, 8 had a suggestive diagnosis, and 8 had no specific diagnosis.

In this study, all of the patients who did not have ITs are currently living, whereas all of the deaths or tranplant occurred in patients who had had ITs. Although the series was small, this observation suggests that the algorithm was utilized appropriately, reserving the most invasive studies for the sickest patients.

In conclusion, this study demonstrates that pediatric ILD comprises a heterogeneous group of mostly rare disorders that present tremendous diagnostic challenges. A systematic approach to the diagnosis of pediatric ILD is useful, and not all patients need lung biopsy for diagnosis.

The authors stress that a systematic evaluation will preclude the need for invasive tests in some patients. Although this series is one of the largest to be reported in ch ildren, the study suffers from small numbers relative to those reported for adult ILD. Because no single pediatric center can see large numbers of pediatric ILD patients, multi center collaboration will be required to extend these observations.

Medindia on Lung cancer:

Lung cancer is the uncontrolled growth of abnormal cells in the lung. Majority of people who get lung cancer have been cigarette smokers, but not all people who smoke get lung cancer. And, some people who have never smoked get lung cancer. Normal lung tissue is made up of cells that are programmed by nature to create lungs of a certain shape and function.
'"/>




Related medicine news :

1. Cancer Risk From Exposure To Diagnostic X-Rays
2. Fragile X-Associated Tremor /Ataxia Syndrome Need Guidelines For Diagnostic Tests
3. Schizophrenia Gets A New Diagnostic Tool
4. Diagnostic Procedure For Tuberculosis Made Easy
5. Apollo Hospitals Short-listed to Provide Diagnostics in the UK
6. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
7. Diagnostic Centre Inaugurated for Air Pollution at SRMC
8. Lab Tests And Diagnostics - Next Wave Of Outsourcing
9. New Diagnostic Tool Uncovered Gene Expression Patterns in Recessive Genetic Disorders
10. eGFR Diagnostic Test -A reliable and understandable measure of kidney impairment
11. Obesity Hinders Medical Diagnostic Tests
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... and clinical outcomes, today released the podcast, “Make Plans for MACRA,” ... value-based payment into the physician's office and how physicians and other clinicians are ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, president ... honored by Enterprising Women magazine as one of its 2017 Enterprising Women of ... owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively support ...
(Date:4/26/2017)... JOHYNSTON, Iowa (PRWEB) , ... April 26, 2017 ... ... agriculture? DuPont Pioneer today launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates ... plants and help farmers produce more and better food, with fewer resources. It ...
(Date:4/25/2017)... San Jose, CA (PRWEB) , ... April 25, ... ... in cross-screen access, support, and collaboration, announces Mirroring360 Pro . This new ... providing a comprehensive collaboration experience for education and business. , Mirroring360 Pro enables ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from the ... for the 2015-16 school year across Wisconsin’s public schools, charter schools, and private ... patterns in student test score performance, the report’s limited analyses fail to provide ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... , April 20, 2017 NeuroVive ... ("NeuroVive") today announced positive preclinical results demonstrating ... compound for non-alcoholic steatohepatitis (NASH), in an ... NV556 has previously shown similar ... model. Today, NeuroVive,s scientists present novel data ...
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
Breaking Medicine Technology: